Literature DB >> 30498843

The empowerment of all modalities against cancer.

Shuting Han1, Han Chong Toh1,2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30498843      PMCID： PMC6250756          DOI： 10.11622/smedj.2018133

Source DB:  PubMed          Journal:  Singapore Med J        ISSN： 0037-5675            Impact factor:   1.858


× No keyword cloud information.
  6 in total

1.  Diagnostic performance of ATA, BTA and TIRADS sonographic patterns in the prediction of malignancy in histologically proven thyroid nodules.

Authors:  Chiaw Ling Chng; Hong Chang Tan; Chow Wei Too; Wei Ying Lim; Priscilla Pei Sze Chiam; Ling Zhu; Nivedita Vikas Nadkarni; Adoree Yi Ying Lim
Journal:  Singapore Med J       Date:  2018-05-18       Impact factor: 1.858

2.  Man against machine: diagnostic performance of a deep learning convolutional neural network for dermoscopic melanoma recognition in comparison to 58 dermatologists.

Authors:  H A Haenssle; C Fink; R Schneiderbauer; F Toberer; T Buhl; A Blum; A Kalloo; A Ben Hadj Hassen; L Thomas; A Enk; L Uhlmann
Journal:  Ann Oncol       Date:  2018-08-01       Impact factor: 32.976

3.  Predictors of depression and anxiety among caregivers of hospitalised advanced cancer patients.

Authors:  Aytül Karabekiroğlu; Esra Yancar Demir; Servet Aker; Birsen Kocamanoğlu; Gamze Sırmalı Karabulut
Journal:  Singapore Med J       Date:  2018-06-07       Impact factor: 1.858

Review 4.  Histologic mimics of malignant melanoma.

Authors:  Caroline Bsirini; Bruce R Smoller
Journal:  Singapore Med J       Date:  2018-05-18       Impact factor: 1.858

5.  Is cryosurgery a feasible local therapy for bone metastatic prostate cancer?

Authors:  Mingxiong Sheng; Lingling Wan; Changming Liu; Chunxiao Liu
Journal:  Singapore Med J       Date:  2018-09-24       Impact factor: 1.858

6.  Local experience with radiosurgery for vestibular schwannomas and recommendations for management.

Authors:  Ru Xin Wong; Hui Ying Terese Low; Daniel Yat Harn Tan
Journal:  Singapore Med J       Date:  2018-09-05       Impact factor: 1.858
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.